Kura Oncology, Inc. (KURA)
9.22
-0.52
(-5.34%)
USD |
NASDAQ |
May 15, 16:00
9.225
0.00 (0.00%)
After-Hours: 20:00
Kura Oncology Shareholders Equity (Quarterly) : 107.88M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Curis, Inc. | 12.71M |
| Novavax, Inc. | -144.76M |
| Capricor Therapeutics, Inc. | 278.70M |
| Agenus, Inc. | -221.22M |
| LadRx Corp. | -2.135M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 652.55M |
| Total Liabilities (Quarterly) | 544.67M |
| Debt to Equity Ratio | 0.225 |
| Current Ratio | 6.146 |
| Net Debt Paydown Yield | -0.21% |